Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electroacupuncture + Dolasetron for PONV in Thoracoscopic Lung Cancer Surgery
NCT07515027Recruiting
- Sponsor
- Shanghai Chest Hospital
- Start
- Apr 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shanghai Chest Hospital. Primary endpoint: Incidence of postoperative nausea and vomiting at 24 hours. Started Apr 2026; status: recruiting.
02
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07515027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07515027.